Clinuvel Pharmaceuticals (CLVLY)

[FarmaZutical]

Probably a bit overvalued after the ASX200 run, then heavy shorting, FDA delayed 3 months and some nervous retailers perhaps.

I’ve never been more sure about this stock than now. Nothing has changed fundamentally and we’re still on track for FDA approval in less than a month.

The first indication is only a foot in the door but still very valuable. In a few years we will probably be NASDAQ listes and have several other indications online as well as the cosmetic line and a pediatric lotion for EPP. We are only approaching the starting line.